Business Context and Reporting Period
This Form 6-K filing by InflaRx N.V. covers the month of August 2021. The company, a foreign private issuer headquartered in Jena, Germany, filed this report to disclose the convening of an extraordinary general meeting of shareholders scheduled for August 25, 2021.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a procedural filing regarding corporate governance and does not contain financial statements or performance data.
Material Changes
No material financial changes versus a prior comparable period are reported in this document. The primary event is the administrative action of notifying shareholders of the upcoming extraordinary general meeting and providing related materials.
Guidance, Outlook, and Risks
The filing does not contain management commentary on financial guidance, future outlook, specific risks, contingencies, or unusual items. The content is limited to the notice of the shareholder meeting and the attachment of the convening notice and voting proxy as exhibits.
Key Facts for Investor Verification
- Extraordinary general meeting of shareholders is scheduled for August 25, 2021.
- Meeting materials, including the agenda and explanatory notes, are attached as Exhibit 99.1.
- A voting proxy form is attached as Exhibit 99.2.
- The report was signed by Niels Riedemann, Chief Executive Officer, on August 10, 2021.